Catherine A. Reardon

10.3k citations

132 papers · 7.7k indexed · 3 hit papers · h-index 47

Molecular Biology top 2%
Surgery top 1%
Immunology top 1%
Physiology top 1%
Epidemiology top 2%

Co-authors: Godfrey S. Getz Paul A. VanderLaan Mary Jo LaDu John R. Lukens Veneracion G. Cabana John M. Taylor T Mazzone Timothy J. Sontag
Topics: Atherosclerosis and Cardiovascular Diseases (36 papers)Cholesterol and Lipid Metabolism (35 papers)Peroxisome Proliferator-Activated Receptors (28 papers)
Cited by: Immunology Physiology Endocrinology, Diabetes and Metabolism
Journals: Science Cell Proceedings of the National Academy of Sciences
Partner nations: United States China Austria

In The Last Decade

Catherine A. Reardon

130 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Animal Models of Atherosclerosis

2012 460 citations Godfrey S. Getz, Catherine A. Reardon profile →
Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids

2018 457 citations Timothy J. Sontag, Catherine A. Reardon et al. profile →
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis

2021 216 citations Chang Cui, Kasturi Chakraborty et al. profile →

Peers

Countries citing papers authored by Catherine A. Reardon

Since Specialization

Citations

This map shows the geographic impact of Catherine A. Reardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine A. Reardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine A. Reardon more than expected).

Fields of papers citing papers by Catherine A. Reardon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine A. Reardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine A. Reardon. The network helps show where Catherine A. Reardon may publish in the future.

Co-authorship network of co-authors of Catherine A. Reardon

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine A. Reardon. A scholar is included among the top collaborators of Catherine A. Reardon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine A. Reardon. Catherine A. Reardon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours 2021 ·Nature Nanotechnology ·Chang Cui,Kasturi Chakraborty,Xu Tang,Kelly Q. Schoenfelt,Alexandria Hoffman,(unknown),(unknown),(unknown),Catherine A. Reardon,Swati Kulkarni,Tomáš Vaisar,Andrea Ballabio,Yamuna Krishnan,Lev Becker	83
2	Obesity and Insulin Resistance Promote Atherosclerosis through an IFNγ-Regulated Macrophage Protein Network 2018 ·Cell Reports ·Catherine A. Reardon,Amulya Lingaraju,Kelly Q. Schoenfelt,Guolin Zhou,Chang Cui,(unknown),(unknown),Andrew N. Hoofnagle,Daniel M. Czyż,Howard A. Shuman,Tomáš Vaisar,Lev Becker	71
3	Plasminogen promotes cholesterol efflux by the ABCA1 pathway 2017 ·JCI Insight ·Nathalie Pamir,Patrick M. Hutchins,Graziella E. Ronsein,Wei Hao,Chongren Tang,Riku Das,Tomáš Vaisar,Edward F. Plow,Volker Schuster,Catherine A. Reardon,Richard B. Weinberg,David A. Dichek,Santica M. Marcovina,Godfrey S. Getz,Jay W. Heinecke	36
4	Natural killer T cells in atherosclerosis 2017 ·Nature Reviews Cardiology ·Godfrey S. Getz,Catherine A. Reardon	76
5	The western-type diet induces anti-HMGB1 autoimmunity in Apoe −/− mice 2016 ·Atherosclerosis ·Yue Pan,Hanzhong Ke,Zhaoqi Yan,Yajun Geng,(unknown),(unknown),Gnanasekar Munirathinam,Subramanyam Dasari,Karin C. Nitiss,Sarah A. Bliss,(unknown),(unknown),Catherine A. Reardon,Godfrey S. Getz,Aoshuang Chen,Guoxing Zheng	15
6	ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis 2016 ·Journal of Lipid Research ·Godfrey S. Getz,Catherine A. Reardon	61
7	Polymorphisms of Mouse Apolipoprotein A-II Alter Its Physical and Functional Nature 2014 ·PLoS ONE ·Timothy J. Sontag,Catherine A. Reardon	1
8	LIGHT/TNFSR14 Can Regulate Hepatic Lipase Expression by Hepatocytes Independent of T Cells and Kupffer Cells 2013 ·PLoS ONE ·(unknown),Ekaterina P. Koroleva,Timothy J. Sontag,Alexei V. Tumanov,Yang‐Xin Fu,Godfrey S. Getz,Catherine A. Reardon	9
9	A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR^–/– mice 2011 ·British Journal of Pharmacology ·Dacheng Peng,Richard A. Hiipakka,Jing‐Tian Xie,Qing Dai,John M. Kokontis,Catherine A. Reardon,Godfrey S. Getz,Shutsung Liao	28
10	Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression 2011 ·Journal of the American College of Cardiology ·Sotirios Tsimikas,Atsushi Miyanohara,Karsten Hartvigsen,Esther Merki,Peter X. Shaw,Meng-Yun Chou,Jennifer Pattison,Michael Torzewski,(unknown),Theodore Friedmann,N. Chin Lai,H. Kirk Hammond,Godfrey S. Getz,Catherine A. Reardon,Andrew C. Li,Carole L. Banka,Joseph L. Witztum	91
11	HDL Apolipoprotein-Related Peptides in the Treatment of Atherosclerosis and other Inflammatory Disorders 2010 ·Current Pharmaceutical Design ·Godfrey S. Getz,Geoffrey D. Wool,Catherine A. Reardon	28
12	Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties 2008 ·Journal of Lipid Research ·Geoffrey D. Wool,Catherine A. Reardon,Godfrey S. Getz	58
13	Antiatherosclerotic Effects of a Novel Synthetic Tissue-Selective Steroidal Liver X Receptor Agonist in Low-Density Lipoprotein Receptor-Deficient Mice 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Dacheng Peng,Richard A. Hiipakka,Qing Dai,Jian Guo,Catherine A. Reardon,Godfrey S. Getz,Shutsung Liao	55
14	VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice 2008 ·Journal of Lipid Research ·Paul A. VanderLaan,Catherine A. Reardon,Ronald A. Thisted,Godfrey S. Getz	52
15	Structure and Evolution of Human Apolipoprotein Genes: Identification of Regulatory Elements of the Human Apolipoprotein E Gene 2007 ·Novartis Foundation symposium ·(unknown),(unknown),Nabil A. Elshourbagy,Catherine A. Reardon,(unknown),David Walker,David J. Chang,Young‐Ki Paik	1
16	Novel proteasome inhibitors show potent anti-tumor efficacy 2004 ·Cancer Research ·K. Nomoto,(unknown),Jiayi Wu,(unknown),Yimin Jiang,Xiangyi Li,Karen TenDyke,(unknown),Catherine A. Reardon,(unknown),(unknown),Pamela D. McGuinness,(unknown),Huiming Zhang,Charles W. Johannes,Jean-Christophe Harmange,M W Vermeulen	1
17	Lipoproteins produced by ApoE–/– astrocytes infected with adenovirus expressing human ApoE 2003 ·Journal of Neurochemistry ·Dacheng Peng,(unknown),Catherine A. Reardon,Shutsung Liao,Godfrey S. Getz	18
18	Mouse models of atherosclerosis 2001 ·Current Opinion in Lipidology ·Catherine A. Reardon,Godfrey S. Getz	61
19	Characterization of an upstream regulatory sequence and its binding protein in the mouse apolipoprotein E gene 1995 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Young‐Ki Paik,Catherine A. Reardon,John M. Taylor,Byung-Kwon Choi	4
20	Effect of dietary lipids on plasma activity and hepatic mRNA levels of cholesteryl ester transfer protein in high-and low-responding baboons (Papio species) 1994 ·Metabolism ·Rampratap S. Kushwaha,Catherine A. Reardon,Douglas S. Lewis,Youlin Qi,Karen Rice,Godfrey S. Getz,K. Dee Carey,Henry C. McGill	9

About Catherine A. Reardon

Catherine A. Reardon is a scholar working on Immunology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 132 papers that have together received 7.7k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (36 papers), Cholesterol and Lipid Metabolism (35 papers) and Peroxisome Proliferator-Activated Receptors (28 papers). The work is most often cited by research in Immunology (2.0k citations), Physiology (1.9k citations) and Endocrinology, Diabetes and Metabolism (903 citations). Catherine A. Reardon has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Godfrey S. Getz, Paul A. VanderLaan, Mary Jo LaDu, John R. Lukens, Veneracion G. Cabana, John M. Taylor, T Mazzone, Timothy J. Sontag, Geoffrey D. Wool and Linda J. Van Eldik. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact